2CDC Diabetes Cost-effectiveness Group. Cost-effective- ness of intensive glycemic control, intensified hyperten- sion control, and serum cholesterol level reduction for type 2 diabetes[J]. JAMA,2002,287(19):2542 2551. 被引量:1
3Gray A, Clarke P, Farmer A, et al. United Kingdom pro- spective diabetes study(UKPDS) group, implementing in- tensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis(UK- PDS 63)[J]. Br Med J,2002,325(7369) :86O-866. 被引量:1
4Lott TF, Blazey ME, West MG. Patient participation in health care: an underused resource[J]. Nurs Clin NorthAm,1992,27(1):61-76. 被引量:1